Safety and Efficacy of Doravirine (MK-1439) in Participants With Human Immunodeficiency Virus 1 (HIV-1) (MK-1439-018)
Clinical trial NCT02275780 · COMPLETED
Trial details
- NCT number
- NCT02275780
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-12-01
- Primary completion
- 2016-09-29
- Enrollment
- 769
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.